Bortezomib With or Without Gemcitabine in Treating Patients With Metastatic Pancreatic Cancer

Clinical trial NCT00052689 · COMPLETED

Trial details

NCT number: NCT00052689
Sponsor: National Cancer Institute (NCI)
Status: COMPLETED
Phase: Phase 2
Study type: INTERVENTIONAL

Duct Cell Adenocarcinoma of the Pancreas Stage IV Pancreatic Cancer

Start date: 2002-12-01
Primary completion: 2007-10-01
Enrollment: 88

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.